MSD has announced European Commission approval for ENFLONSIA™ (clesrovimab) for the prevention of RSV lower respiratory tract disease in newborns and infants during their first RSV season.
New research published by Minister Jennifer Murnane O’Connor highlights the relationship between social deprivation and addiction treatment demand across Ireland.
Bayer has announced that the HSE has granted hospital pricing approval for EYLEA® 8mg for eligible adult patients with wet age-related macular degeneration and diabetic macular oedema in Ireland.
The first authorised treatment for epidermolysis bullosa in Ireland has been made available, marking a major milestone for patients living with the painful rare skin condition.
The Government has finalised new framework agreements with Medicines for Ireland and the Irish Pharmaceutical Healthcare Association to improve access to medicines and strengthen supply security.
HIQA has launched a six-week public consultation on draft national guidance to support the safe and responsible use of artificial intelligence across health and social care services in Ireland.
Uniphar has announced the acquisition of Irish health technology provider TouchStore, supporting further digital innovation across medicines supply and dispensing systems.
Minister for Mental Health Mary Butler has announced a €3 million investment in mental health research, including a new all-island collaborative research network.